Trial Profile
Clinical Evaluation of Bupropion SR (323U66) in Patients With Depression - Investigation in Elderly Patients With Depression.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Sep 2023
Price :
$35
*
At a glance
- Drugs Bupropion (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 19 Mar 2009 Actual patient number (35) added as reported by ClinicalTrials.gov.
- 19 Mar 2009 Official Title amended as reported by ClinicalTrials.gov.
- 15 Oct 2008 Trial phase changed from III to II as reported by ClinicalTrials.gov.